NOD2 and obesity due to melanocortin 4 receptor deficiency: NOD2 activation after injection of MDP promotes immune tolerance, lowers adipose tissue inflammation, and improves blood glucose control during low‐dose endotoxin challenge and during obesity (Cavallari et al., 2017).